Integration of Fe3O4 with Bi2S3 for Multi-Modality Tumor Theranostics

References

Loading, please wait
ref
title
DOI
material type
comment
172Integration of Fe3O4 with Bi2S3 for Multi-Modality Tumor Theranosticshttps://doi.org/10.1021/acsami.0c05088CompositeFe3O4@PDA@BSA-Bi2S3

Materials

Loading, please wait
ref
material
size
size err
size unit
size type
size comment
BET
b nanozyme
b 10n
b unit
specific act
sa 10n
sa unit
comment
172Fe3O4@PDA@BSA-Bi2S3120, 125, and 123nmDLSThe DLS size of Fe3O4@PDA@BSA-Bi2S3 NPs were indicated as 120, 125, and 123 nm, respectively, and showed no detectable fluctuation during the 5 days storage

Kinetics

Loading, please wait
ref
material
enzyme type
substrate
pH
T
km
km err
km 10n
km unit
vmax
vmax err
vmax 10n
vmax unit
kcat
kcat err
kcat 10n
kcat unit
kcat/km
kcat/km 10n
kcat/km unit
comment
172Fe3O4@PDA@BSA-Bi2S3PODH2O267.04mM2.2-8M/s172

Applications

Loading, please wait
ref
material
application
target
method
linear range
linear ran unit
LOD
lod unit
recovery
comment
172Fe3O4@PDA@BSA-Bi2S3a Fe3O4@PDA@BSA-Bi2S3 composite theranostic agent was successfully prepared for synergistic tumor PTT and CDT, in which the BSA coating endows the NPs with colloidal stability and both in vitro and in vivo biocompatibility.